作者: Joel Lexchin , Barbara Mintzes
DOI: 10.1509/JPPM.21.2.194.17595
关键词:
摘要: Abstract There is little rationale for direct-to-consumer advertising of prescription drugs. Most new drugs offer if any therapeutic advantage over existing products. Direct-to-consumer advertisements frequently downplay safety information. Physicians are highly ambivalent about prescribing advertised requested by patients. no evidence that results in improvement health outcomes.